Table 1. Baseline characteristics (n = 170).
| Characteristics | Value |
| Demographic data | |
| Age (years) | 45.3±15.1 |
| Male gender, no. (%) | 102 (60.0) |
| Body mass index (kg/m2) | 23.4±2.8 |
| Laboratory data | |
| Serum albumin (g/dL) | 4.2±0.51 |
| Total bilirubin (mg/dL) | 1.26±0.90 |
| Aspartate aminotransferase (IU/L) | 45.9±21.3 |
| Alanine aminotransferase (IU/L) | 62.9±26.1 |
| Prothrombin time (%) | 90.2±13.9 |
| Platelet count (109/L) | 183.9±73.3 |
| Biopsy length (mm) | 21.3±0.7 |
| Enhanced liver fibrosis test | 9.56±1.69 |
| Liver stiffness (kPa) | 12.24±7.76 |
| FibroTest | 0.55±0.30 |
| Fibrosis stage, no. (%) | |
| F0 | 10 (5.9%) |
| F1 | 39 (22.9%) |
| F2 | 36 (21.2%) |
| F3 | 38 (22.4%) |
| F4 | 47 (27.6%) |
Values were expressed as mean ± standard deviation, unless indicated otherwise.